Xcout Intel
Vaderis Therapeutics
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Subscribe to see Vaderis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vaderis Therapeutics at a glance
Vaderis Therapeutics is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series B, raised $152.5M in August 2026. Xcout tracks 1 named person at Vaderis Therapeutics, including Azmi Nabulsi (President and Chief Executive Officer).
Vaderis Therapeutics leadership
- Azmi NabulsiPresident and Chief Executive Officer
Vaderis Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $152.5M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Vaderis Therapeutics competitors
A few of Vaderis Therapeutics's closest competitors — see the full list of competitors and alternatives →
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Granite Bio is a biotechnology company headquartered in Basel, Switzerland. It is developing first-in-class therapies by targeting fundamentals of biology and debuted with $100 million of capital.
VAXIMM AG is a biotech company headquartered in Basel, Switzerland, that focuses on developing a new class of cytotoxic immunotherapies and clinical-stage targeted treatments through its subsidiaries.
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Windward Bio is a clinical-stage biotechnology and drug development company headquartered in Basel, Switzerland. It is committed to improving outcomes for people living with serious immunological diseases through its deep discovery, development, and commercialization expertise.
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
Get Vaderis Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vaderis Therapeutics in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access